期刊文献+

Padua评分模型和出血风险评估模型在行经内镜逆行胰胆管造影术老年胆总管结石患者静脉血栓栓塞症和出血风险因素分析中的应用 被引量:4

Using the Padua prediction score and the bleeding risk score for the assessment of venous thromboembolism and hemorrhage risk factors in elderly patients with choledocholithiasis undergoing endoscopic retrograde cholangiopancreatography
原文传递
导出
摘要 目的探讨Padua评分及出血风险评估模型在行经内镜逆行胰胆管造影术(ERCP)的老年胆总管结石患者静脉血栓栓塞症(VTE)和出血风险因素分析中的应用。方法回顾性分析2017年9月至2019年9月新疆医科大学第一附属医院消化科收治的171例行ERCP治疗的老年胆总管结石患者临床资料,研究VTE、出血危险因素及发生情况,评估Padua风险评估及出血风险评估模型对患者进行VTE及出血分层的应用价值。结果171例患者均顺利完成手术,18例发生并发症,包括术后胰腺炎(9例)、胆道感染(4例)、出血(3例)、VTE事件(2例),不同年龄分层的老年患者均有术后并发症发生,但发生率差异无统计学意义(P>0.05)。根据评估模型,32.7%(56/171)为VTE高危患者,15.2%(26/171)为出血高危患者,2例VTE事件均发生在高危组,3例出血事件中2例发生在低危组、1例发生在高危组。高危组及低危组患者并发症的发生率差异均无统计学意义(χ^(2)=0.000、2.867,P=1.000、0.090)。Logistic回归分析结果显示,Padua风险评估模型(OR=8.383、95%CI:0.926~75.869、P=0.059)、出血风险评估模型(OR=2.860、95%CI:0.250~32.740、P=0.398)并非发生VTE/出血的影响因素。结论对于老年胆总管结石行ERCP患者,Padua评分及出血风险评估模型风险预测能力有限,需要更注重恶性肿瘤、既往VTE病史这两项VTE风险因素及抗血栓药物服用史的出血风险。 Objective To analyze the value of the Padua prediction score and the bleeding risk score in the risk assessment of venous thromboembolism(VTE)and hemorrhage in elderly patients with choledocholithiasis during endoscopic retrograde cholangiopancreatography(ERCP).Methods Clinical data of 171 elderly patients with choledocholithiasis treated with ERCP at the Affiliated Hospital of Xinjiang Medical University from September 2017 to September 2019 were retrospectively analyzed.The Padua prediction score and bleeding risk score were used to evaluate the occurrence of VTE and hemorrhage risk stratification.Results Of all patients treated with the procedure,18 of them had complications after surgery,including postoperative pancreatitis(9 cases),biliary infections(4 cases),hemorrhage(3 cases)and VTE events(2 cases).In addition,complications occurred in elderly patients in different age groups,with no significant difference in incidence(all P>0.05).Evaluation models showed that 32.7%(56/171)were at high risk for VTE,and 15.2%(26/171)were at high risk for hemorrhage.Furthermore,2 VTE events occurred in the high-risk group and,of 3 hemorrhage events,2 were occurred in the low-risk group and 1 in the high-risk group.There was no significant difference in the incidence of complications between the high-risk group and the low-risk group(χ2=0.000,2.867,P=1.000,0.090).Logistic regression analysis results showed that scores of the two assessment models were not influencing factors for VTE/hemorrhage(Padua prediction score:OR=8.383,95%CI:0.926-75.869,P=0.059;bleeding risk score:OR=2.860,95%CI:0.250-32.740,P=0.398).Conclusions For elderly choledocholithiasis patients treated with ERCP,the Padua prediction score and the bleeding risk score have limited ability for risk assessment.More attention needs to be paid to the two VTE risk factors,i.e.,malignant tumors and previous VTE history,in addition to previous bleeding risk for antithrombotic therapy.
作者 阿合包塔·白布提汗 张志强 夏宇 高鸿亮 Ahebaota Baibutihan;Zhang Zhiqiang;Xia Yu;Gao Hongliang(Department of Gastroenterology,the Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China;Department of Nephrology Xinjiang Medical University,Urumqi 830054,China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2022年第6期695-699,共5页 Chinese Journal of Geriatrics
关键词 胰胆管造影术 内窥镜逆行 胆总管结石 静脉血栓栓塞症 出血 Cholangiopancreatography,endoscopic retrograde Choledocholithiasis Venous thromboembolism Hemorrhage
  • 相关文献

参考文献8

二级参考文献27

  • 1Hong-Chuan Zhao,Liang He,Da-Chen Zhou,Xiao-Ping Geng,Fa-Ming Pan.Meta-analysis comparison of endoscopic papillary balloon dilatation and endoscopic sphincteropapillotomy[J].World Journal of Gastroenterology,2013,19(24):3883-3891. 被引量:27
  • 2陈剑,韦军民.术中微切开胆道镜检查的可行性研究[J].中华肝胆外科杂志,2005,11(6):372-374. 被引量:35
  • 3马艳,张庆华.新疆维吾尔族正常人群抗活化的蛋白C发生率的调查[J].中华血液学杂志,1996,17(9):468-468. 被引量:5
  • 4LIU H W’KWONG Y L,BOURKE C,et al. High in-cidence of thrombophilia detected in Chinese patientswith venous thrombosis[J]. Thromb Haemost, 1994,71 :416-419.
  • 5SHEN M C,UN J S,TSAY W. High prevalence ofantithromb III,protein C and protein S deficiency,butno factor V Leiden mutation in venous thrombophilicChinese patients in Taiwan[J]. Thromb Res,1997,87:377-385.
  • 6LIJFERING W M,BROUWER J L’VEEGER N J,etal. Selective testing for thrombophilia in patients withfirst venous thrombosis: results from a retrospectivefamily cohort study on absolute thrombotic risk forcurrently known thrombophilic defects in 2 479 rela-tives[J]. Blood,2009,113:5314-5322.
  • 7MIYAKIS S’LOCKSHIN M D,ATSUMI T,et al. In-ternational consensus statement on an update of theclassification criteria for definite antiphospholipidsyndrome (APS) [J], J Thromb Haemost,2006,4 :295 - 306.
  • 8KEELING D,MACKIE I,MOORE G W,et al. Guide-lines on the investigation and management of an-tiphospholipid syndrome [J]. Br J Haematol,2012,157:47-58.
  • 9SMALBERG J H,KRUIP M J JANSSEN H L,et al.Hypercoagulability and hypofibrinolysis and risk ofdeep vein thrombosis and splanchnic vein thrombosis:similarities and differences [J]. Arterioscler ThrombVase Biol,2011 .31:485 -493.
  • 10DENTALI F, SQUIZZATO A,BRIVIO L, et al.JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venousthromboembolism: a meta-analysis [J]. Blood,2009,113:5617-5623.

共引文献214

同被引文献47

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部